How a label gets onto the right container

The failure this whole subpart is built around

Almost every question about a peptide vial is about what is inside it. There is a separate failure that no test of the contents can catch.

It is the correct product in the correct container with the wrong label on the outside. Nothing about it looks wrong. The liquid is what it should be, the seal is intact, and the printing is clean.

Federal manufacturing rules have a whole subpart aimed at that single problem. It is titled packaging and labeling control, and it treats printed labels as a material to be received, examined, stored, issued, counted and destroyed.

The reason this is worth reading is not that it settles anything about a particular company. It is that it turns a vague worry into a short list of specific practices, and specific practices can be asked about.

A label is a controlled material, not stationery

The first rule requires written procedures describing, in sufficient detail, the receipt, identification, storage, handling, sampling, examination and testing of labeling and packaging materials. The procedures then have to be followed.

Labeling and packaging materials have to be representatively sampled and examined or tested on receipt and before use. Materials that meet written specifications may be approved and released. Materials that do not have to be rejected, so they cannot be used in operations they are unsuitable for.

Records are kept for each shipment of each different labeling and packaging material, showing receipt, examination or testing, and whether it was accepted or rejected.

Then the rule that reads like a warehouse instruction and is really a safety rule. Labels for each different drug product, strength, dosage form or quantity of contents have to be stored separately with suitable identification, and access to that storage area has to be limited to authorized personnel.

Obsolete and outdated labels, labeling and packaging materials have to be destroyed. Not archived, not shelved for later.

The printing rule that explains a lot of recalls

Printers save money by laying several different labels onto one sheet and cutting them afterwards. The regulation has a name for that and a rule about it.

Gang-printed labeling for different drug products, or for different strengths or net contents of the same product, is prohibited unless the labeling from those sheets is adequately differentiated by size, shape or color.

The clause worth noticing is the middle one. Different strengths of the same product are treated with the same suspicion as different products entirely, because that is the pair most likely to be confused.

Color, size and shape are the named differentiators, and they are all things a person can see across a room. The rule is not asking for a better proofreading step. It is asking for a difference that survives inattention.

Four ways to make a mislabel impossible, and you pick one

Where cut labeling is used for immediate container labels or unit cartons, the regulation requires one of four special control procedures. Any one of them, but one of them.

The first is dedicating labeling and packaging lines to each different strength of each different product, so two products never share a line.

The second is electronic or electromechanical equipment conducting a complete examination for correct labeling during or after finishing operations.

The third is visual inspection conducting the same complete examination for hand-applied labeling, and it carries a condition. That examination has to be performed by one person and independently verified by a second person.

The fourth is any automated technique, including differentiation by labeling size and shape, that physically prevents incorrect labeling from being processed by the equipment.

The third option is the one to notice on a small-scale operation, because hand-applied labeling is what small-scale usually means. The regulation does not forbid it. It requires a second pair of eyes.

Counting the labels back

Issuing labels for a batch is its own controlled step, with its own short section.

Strict control has to be exercised over labeling issued for labeling operations. Labeling issued for a batch has to be carefully examined for identity and for conformity to the labeling specified in the master or batch production records.

Then the arithmetic. Procedures have to reconcile the quantities of labeling issued, used and returned. Where the discrepancy between the quantity of product finished and the quantity of labeling issued falls outside narrow preset limits based on historical operating data, it has to be investigated.

Excess labeling bearing lot or control numbers has to be destroyed. Returned labeling has to be stored in a manner that prevents mixups and provides proper identification.

Reconciliation is waived in one stated case, where a complete examination for correct labeling is performed by the equipment route above. That is the trade the regulation offers: count them, or check every one.

Clearing the line before anything is filled

Packaging and labeling operations have their own written procedures, and the regulation lists the features those procedures have to incorporate.

Mixups and cross-contamination are prevented by physical or spatial separation from operations on other drug products. Filled containers held in an unlabeled condition for future labeling have to be identified well enough to determine the name, strength, quantity of contents and lot or control number. The identification need not be applied to each individual container.

The product is identified with a lot or control number that permits determination of the history of the manufacture and control of the batch.

Packaging and labeling materials are examined for suitability and correctness before packaging operations, and that examination is documented in the batch production record.

And the facilities themselves are inspected immediately before use, to assure that all products have been removed from previous operations and that unsuitable materials have been removed. That inspection is documented too.

Every one of those five is a written record with a date on it, which is why an inspection of a facility is capable of finding anything at all.

Somebody looks at the finished units, and somebody reads the paperwork

Two more checks sit at the end of the line, one physical and one on paper.

Packaged and labeled products are examined during finishing operations to give assurance that containers and packages in the lot carry the correct label. A representative sample of units is collected at the completion of finishing operations and visually examined for correct labeling. The results go into the batch production or control records.

The batch record itself is required to hold specific things about labeling. It carries the inspection of the packaging and labeling area before and after use. It carries complete labeling control records, including specimens or copies of all labeling used. And it carries the results of the finished-unit examination.

A physical specimen of the label goes into the file. That is what makes a later question about a batch answerable rather than a matter of recollection.

Then the review. Production and control records, including those for packaging and labeling, are reviewed and approved by the quality control unit before a batch is released or distributed.

Any unexplained discrepancy has to be thoroughly investigated, whether or not the batch has already been distributed, and the investigation extends to other batches and other products that may be associated with the same failure. A written record of the investigation is made, including conclusions and follow-up.

The container is a component, not a wrapper

One section over from the labeling rules sits a short one about the container and its closure, and it is the reason a vial is not simply glass.

Containers and closures may not be reactive, additive or absorptive in a way that alters the safety, identity, strength, quality or purity of the drug beyond the established requirements.

The container closure system has to provide adequate protection against foreseeable external factors in storage and use that can cause deterioration or contamination.

Containers and closures have to be clean and, where the nature of the drug indicates it, sterilized and processed to remove pyrogenic properties, with those processes validated. Written standards, test methods and, where indicated, cleaning and sterilizing methods have to exist and be followed.

The word doing the work is "system". A stopper, a seal and a vial are assessed together against the product they hold, not judged separately as parts.

Who these rules are addressed to, and the rule people expect to find

The part states its own reach in its first section: it sets the minimum current good manufacturing practice for preparing drug products for administration to humans or animals. Which compounders that reaches is settled by the compounding provisions of the statute rather than by this part, and those provisions are covered separately here.

So the correct way to read everything above is as the standard a manufacturing operation works to, not as a duty this site is placing on anyone.

One more scope line, because readers go looking for it. The tamper-evident packaging section in this same subpart is written on its own face for over-the-counter drug products for retail sale, with named exceptions. It says a covered product not packaged or labeled that way is adulterated or misbranded.

That section also states that it does not affect requirements for special packaging under the Poison Prevention Packaging Act. Its own scope is what it says it is, and nothing here is a claim about what other rules elsewhere may require.

What a buyer can actually do with this

These are manufacturing controls, and a buyer is never going to audit them. They are still useful, because they convert an anxious question into an answerable one.

Instead of asking whether a preparation is trustworthy, the questions become narrow. Does the vial label match the carton label in product, strength and quantity? Does the lot number on the vial match the lot number on any certificate that came with it?

Is there a second label anywhere in the package that disagrees with the first? Do two vials from the same order carry the same lot number, and does that match what the paperwork says?

A mismatch is worth raising with the dispenser named on the box, and the batch records that would settle it are the pharmacy's to consult rather than yours.

And the point that survives all of it: the reason a mislabeled vial has this much machinery around it is that it is invisible to the person holding the vial. Nothing you can see, smell or measure at home tells you the label is the right one.

Sources

Each document below is named as it names itself, with the date printed on that document rather than the day it was read.

1. Title 21 Code of Federal Regulations Section 211.122, Materials examination and usage criteria, read in full including the separate-storage and limited-access requirement at paragraph (d), the destruction of obsolete labeling at paragraph (e), the gang-printing prohibition at paragraph (f) and the four special control procedures at paragraph (g) — Electronic Code of Federal Regulations, Office of the Federal Register, March 2012
2. Title 21 Code of Federal Regulations Section 211.125, Labeling issuance, read in full including the reconciliation of quantities issued, used and returned at paragraph (c) and the destruction of excess labeling bearing lot or control numbers at paragraph (d) — Electronic Code of Federal Regulations, Office of the Federal Register, June 2024
3. Title 21 Code of Federal Regulations Section 211.130, Packaging and labeling operations, read in full including the physical or spatial separation requirement and the inspection of facilities immediately before use at paragraph (e) — Electronic Code of Federal Regulations, Office of the Federal Register, August 1993
4. Title 21 Code of Federal Regulations Section 211.134, Drug product inspection, carrying no amendment bracket of its own and taking its printed date from the source note for part 211 — Electronic Code of Federal Regulations, Office of the Federal Register, September 1978
5. Title 21 Code of Federal Regulations Section 211.132, Tamper-evident packaging requirements for over-the-counter (OTC) human drug products, read for its own statement of scope and its clause on special packaging under the Poison Prevention Packaging Act — Electronic Code of Federal Regulations, Office of the Federal Register, June 2024
6. Title 21 Code of Federal Regulations Section 211.94, Drug product containers and closures — Electronic Code of Federal Regulations, Office of the Federal Register, June 2024
7. Title 21 Code of Federal Regulations Section 211.1, Scope, stating that the part contains the minimum current good manufacturing practice for preparation of drug products for administration to humans or animals — Electronic Code of Federal Regulations, Office of the Federal Register, June 2024
8. Title 21 Code of Federal Regulations Section 211.188, Batch production and control records, including the inspection of the packaging and labeling area before and after use at paragraph (b)(6), the complete labeling control records and specimens at paragraph (b)(8), and the results of the drug product inspection at paragraph (b)(13) — Electronic Code of Federal Regulations, Office of the Federal Register, September 2008
9. Title 21 Code of Federal Regulations Section 211.192, Production record review, requiring quality control unit review before release and the thorough investigation of any unexplained discrepancy whether or not the batch has already been distributed — Electronic Code of Federal Regulations, Office of the Federal Register, September 1978